RPG Life Sciences Limited Cash Flow Conversion Efficiency

Latest as of September 2025: 0.020x

RPG Life Sciences Limited cash flow conversion efficiency. Based on the latest financial reports, RPG Life Sciences Limited (RPGLIFE) has a cash flow conversion efficiency ratio of 0.020x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs112.70 Million ≈ $1.22 Million USD) by net assets (Rs5.54 Billion ≈ $59.91 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of RPG Life Sciences Limited (2005–2026)

Cash flow conversion efficiency of RPG Life Sciences Limited from 2005 to 2026. This chart illustrates how RPG Life Sciences Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View RPGLIFE stock price for real-time trading data and today's change.

RPG Life Sciences Limited Cash Flow Conversion Ratio Explained

RPG Life Sciences Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

RPG Life Sciences Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of RPG Life Sciences Limited ranked by their cash flow conversion efficiency. Also see RPG Life Sciences Limited market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Jiangxi Huawu Brake Co Ltd SHE:300095	0.038x
MiCo Ltd KQ:059090	0.027x
QUADIENT SA ADR1/15/EO 1 F:NEQ0	N/A
Beijing Tongyizhong New Material Technology Corp SHG:688722	0.020x
Polynovo Ltd AU:PNV	0.110x
Everbright Jiabao Co Ltd SHG:600622	0.042x
Kneat.com Inc TO:KSI	-0.047x
Puradelta Lestari PT JK:DMAS	-0.022x

Annual Cash Flow Conversion Efficiency for RPG Life Sciences Limited (2005–2026)

The table below shows the annual cash flow conversion efficiency of RPG Life Sciences Limited from 2005 to 2026. Review free cash flow generation of RPG Life Sciences Limited to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2026-03-31	Rs6.05 Billion ≈ $65.47 Million	Rs652.80 Million ≈ $7.06 Million	0.108x	-26.52%
2025-03-31	Rs5.31 Billion ≈ $57.37 Million	Rs778.60 Million ≈ $8.42 Million	0.147x	-41.70%
2024-03-31	Rs3.75 Billion ≈ $40.54 Million	Rs943.60 Million ≈ $10.20 Million	0.252x	-14.74%
2023-03-31	Rs3.08 Billion ≈ $33.27 Million	Rs908.20 Million ≈ $9.82 Million	0.295x	+16.63%
2022-03-31	Rs2.56 Billion ≈ $27.66 Million	Rs647.50 Million ≈ $7.00 Million	0.253x	-5.96%
2021-03-31	Rs2.16 Billion ≈ $23.41 Million	Rs582.70 Million ≈ $6.30 Million	0.269x	-5.25%
2020-03-31	Rs1.77 Billion ≈ $19.10 Million	Rs501.70 Million ≈ $5.43 Million	0.284x	-0.38%
2019-03-31	Rs1.60 Billion ≈ $17.36 Million	Rs457.80 Million ≈ $4.95 Million	0.285x	+200.68%
2018-03-31	Rs1.55 Billion ≈ $16.74 Million	Rs146.80 Million ≈ $1.59 Million	0.095x	+93.85%
2017-03-31	Rs1.54 Billion ≈ $16.66 Million	Rs75.40 Million ≈ $815.42K	0.049x	-80.08%
2016-03-31	Rs1.34 Billion ≈ $14.45 Million	Rs328.10 Million ≈ $3.55 Million	0.246x	+1660.38%
2015-03-31	Rs1.25 Billion ≈ $13.54 Million	Rs-19.70 Million ≈ $-213.05K	-0.016x	+64.40%
2014-03-31	Rs1.26 Billion ≈ $13.60 Million	Rs-55.60 Million ≈ $-601.29K	-0.044x	-127.36%
2013-03-31	Rs762.30 Million ≈ $8.24 Million	Rs123.20 Million ≈ $1.33 Million	0.162x	-23.92%
2012-03-31	Rs741.40 Million ≈ $8.02 Million	Rs157.50 Million ≈ $1.70 Million	0.212x	+10.23%
2011-03-31	Rs748.31 Million ≈ $8.09 Million	Rs144.21 Million ≈ $1.56 Million	0.193x	-39.62%
2010-03-31	Rs644.31 Million ≈ $6.97 Million	Rs205.66 Million ≈ $2.22 Million	0.319x	-39.17%
2009-03-31	Rs549.21 Million ≈ $5.94 Million	Rs288.19 Million ≈ $3.12 Million	0.525x	-4.46%
2008-03-31	Rs492.02 Million ≈ $5.32 Million	Rs270.23 Million ≈ $2.92 Million	0.549x	+166.15%
2007-03-31	Rs742.36 Million ≈ $8.03 Million	Rs153.19 Million ≈ $1.66 Million	0.206x	+67.70%
2006-03-31	Rs667.72 Million ≈ $7.22 Million	Rs82.17 Million ≈ $888.59K	0.123x	-71.98%
2005-03-31	Rs150.60 Million ≈ $1.63 Million	Rs66.13 Million ≈ $715.16K	0.439x	--

About RPG Life Sciences Limited

NSE:RPGLIFE India Drug Manufacturers - Specialty & Generic

Market Cap

$452.45 Million

Rs41.84 Billion INR

Market Cap Rank

#12426 Global

#619 in India

Share Price

Rs2529.60

Change (1 day)

-0.78%

52-Week Range

Rs1744.00 - Rs3089.20

All Time High

Rs3089.20